Clinical Trials on Mixed Dyslipidemias
Total 3929 results
-
National Research Council, SpainCompleted
-
Ajinomoto Foods Europe SASNaturalpha; Institut Polytechnique LaSalle BeauvaisCompleted
-
NovartisCompletedDyslipidemiaGermany, United States
-
University of MiamiHumana Inc.Completed
-
Merck Sharp & Dohme LLCCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiaKorea, Republic of
-
Pronova BioPharmaTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Hospital de Clinicas de Porto AlegreCompleted
-
Xention LtdCompletedDyslipidemiaDenmark, Netherlands
-
University of California, San DiegoNational Heart, Lung, and Blood Institute (NHLBI)CompletedDyslipidemiasUnited States
-
China Academy of Chinese Medical SciencesCompleted
-
New York Hospital QueensNYHQ Cardiac Health Center; Pivotal TherapeuticsUnknown
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Akros Pharma Inc.Completed
-
University of Nevada, Las VegasCompleted
-
AstraZenecaWithdrawn
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
University of WashingtonUpsher-Smith LaboratoriesCompleted
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.Completed
-
Lewai Sharki Abdulaziz, MSc PhDAl-Kindy College of MedicineCompletedAtherogenic Dyslipidemia | Obesity Associated DisorderIraq
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Jeil Pharmaceutical Co., Ltd.CompletedHypertension With DyslipidemiaKorea, Republic of
-
University of PaviaFoundation IRCCS San Matteo HospitalRecruiting
-
Shenzhen Center for Chronic Disease ControlSun Yat-sen University; Shenzhen Qilinshan SanatoriumCompletedDyslipidemia | Dysglycemia
-
University Medical Centre LjubljanaCompletedDyslipidemia | TransplantsSlovenia
-
AstraZenecaParexelNot yet recruiting
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDyslipidemia | Cardiovascular
-
IRCCS Policlinico S. MatteoUniversity of PaviaCompleted
-
University of Rome Tor VergataCompletedType 2 Diabetes | Diabetic DyslipidemiaItaly
-
AstraZenecaParexelRecruiting
-
GWT-TUD GmbHActive, not recruitingDyslipoproteinemiasGermany
-
Gaia AGUniversity Hospital, Aachen; Deutsche Stiftung für chronisch KrankeNot yet recruitingDyslipidemias | HypercholesterolemiaGermany
-
EMSRecruitingDyslipidemia | HypertriglyceridemiaBrazil
-
The George Institute for Global Health, ChinaNingxia Medical UniversityCompletedCardiovascular Diseases | DyslipidemiasChina
-
Organon and CoCompletedDyslipidemia | Hypercholesterolemia
-
Yonsei UniversityCompletedDyslipidemias | HypercholesterolemiaKorea, Republic of
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
Casa de Saúde santa MarcelinaCompleted
-
University of ChilePontificia Universidad Catolica de ChileCompletedDyslipidemias | HypercholesterolemiaChile
-
Wenzhou Medical UniversityTerminated
-
PfizerWithdrawnDyslipidemia | Hypercholesterolemia
-
AbbottCompletedDyslipidemiaArgentina, Czech Republic, Germany, Mexico, Poland, Romania, Russian Federation
-
Zydus Lifesciences LimitedCompletedDyslipidemia | HypertriglyceridemiaIndia